Please provide your email address to receive an email when new articles are posted on . IGA success rates and lesion count reductions were higher in those treated with Emrosi vs. placebo or Oracea.

A low-dose (40 mg) modified formulation of minocycline hydrochloride (DFD-29) was better tolerated and more effective than doxycycline and placebo in patients with moderate to severe ...